Market Access News | pharmaphorum

News

Turkey's home-grown COVID vaccine project nears fruition

Turkey could have its own COVID-19 vaccine Turkovac available for use by the end of the year, according to the country's Health Minister Fahrettin Koca.

News

After Scotland says no, NICE backs Lilly's Retsevmo for lung...

Eli Lilly's RET inhibitor Retsevmo can now be prescribed on the NHS for people with RET fusion-positive advanced non-small cell lung cancer (NSCLC) in England and Wales, within the Cancer D

News

FDA clears Takeda drug for post-transplant CMV infections

Takeda has scored the first-ever FDA approval of a treatment for refractory cytomegalovirus (CMV) infections in organ transplant patients, which can lead to an increased risk of complicatio

News

Hepatitis Virus - 3d rendered illustration

Gilead files first hepatitis delta therapy with FDA

Gilead Sciences has submitted its marketing application for bulevirtide, its antiviral therapy for rare hepatitis delta virus (HDV) infections, to the FDA.

News

Young lonely man in a wheelchair on a balcony looking at the nature in the spring

NICE reaches a deal with Roche on access to oral SMA drug Ev...

Roche's oral treatment Evrysdi for the rare genetic disease spinal muscular atrophy (SMA) will be made available on the NHS in England, after NICE reached a three-year access agreement with

News

NICE backs ViiV/J&J's six-per-year injection for HIV

People living with HIV in England and Wales now have an alternative to daily oral tablets, after NICE backed NHS use of two long-acting injectable therapies developed by ViiV Healthcare and

Turkey's home-grown COVID vaccine project nears fruition

After Scotland says no, NICE backs Lilly's Retsevmo for lung...

FDA clears Takeda drug for post-transplant CMV infections

Gilead files first hepatitis delta therapy with FDA

NICE reaches a deal with Roche on access to oral SMA drug Ev...

NICE backs ViiV/J&J's six-per-year injection for HIV

FDA starts review of Regeneron's drug for rare disease FOP

How to meet your physicians where they are online

News

Editor's Picks